vs
NPK International Inc.（NPKI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
NPK International Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$75.2M vs $69.8M），NPK International Inc.同比增速更快（30.7% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 23.9%）
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NPKI vs RIGL — 直观对比
营收规模更大
NPKI
是对方的1.1倍
$69.8M
营收增速更快
NPKI
高出9.5%
21.2%
两年增速更快
RIGL
近两年复合增速
23.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.2M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 37.7% | 91.5% |
| 营业利润率 | 16.7% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 30.7% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.17 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NPKIRIGL
| Q4 25 | $75.2M | $69.8M | ||
| Q3 25 | $68.8M | $69.5M | ||
| Q2 25 | $68.2M | $101.7M | ||
| Q1 25 | $64.8M | $53.3M | ||
| Q4 24 | $57.5M | $57.6M | ||
| Q3 24 | $44.2M | $55.3M | ||
| Q2 24 | $66.8M | $36.8M | ||
| Q1 24 | $49.0M | $29.5M |
净利润NPKIRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $5.7M | $27.9M | ||
| Q2 25 | $8.7M | $59.6M | ||
| Q1 25 | $10.0M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $-174.3M | $12.4M | ||
| Q2 24 | $8.0M | $-1.0M | ||
| Q1 24 | $7.3M | $-8.2M |
毛利率NPKIRIGL
| Q4 25 | 37.7% | 91.5% | ||
| Q3 25 | 31.9% | 93.2% | ||
| Q2 25 | 36.9% | 95.6% | ||
| Q1 25 | 39.0% | 91.7% | ||
| Q4 24 | 39.2% | 89.9% | ||
| Q3 24 | 27.5% | 85.5% | ||
| Q2 24 | 37.2% | 92.4% | ||
| Q1 24 | 36.0% | 93.1% |
营业利润率NPKIRIGL
| Q4 25 | 16.7% | 33.2% | ||
| Q3 25 | 13.2% | 40.9% | ||
| Q2 25 | 17.0% | 60.1% | ||
| Q1 25 | 20.9% | 23.9% | ||
| Q4 24 | 20.2% | 28.9% | ||
| Q3 24 | 2.8% | 25.4% | ||
| Q2 24 | 18.7% | 1.2% | ||
| Q1 24 | 14.2% | -23.6% |
净利率NPKIRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 8.2% | 40.2% | ||
| Q2 25 | 12.7% | 58.6% | ||
| Q1 25 | 15.4% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | -394.3% | 22.5% | ||
| Q2 24 | 12.0% | -2.8% | ||
| Q1 24 | 14.9% | -27.9% |
每股收益（稀释后）NPKIRIGL
| Q4 25 | $0.17 | $14.11 | ||
| Q3 25 | $0.07 | $1.46 | ||
| Q2 25 | $0.10 | $3.28 | ||
| Q1 25 | $0.11 | $0.63 | ||
| Q4 24 | $0.10 | $0.82 | ||
| Q3 24 | $-1.99 | $0.70 | ||
| Q2 24 | $0.09 | $-0.06 | ||
| Q1 24 | $0.08 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $155.0M |
| 总债务越低越好 | $16.9M | $52.5M |
| 股东权益账面价值 | $351.2M | $391.5M |
| 总资产 | $441.8M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.05× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NPKIRIGL
| Q4 25 | $5.1M | $155.0M | ||
| Q3 25 | $35.6M | $137.1M | ||
| Q2 25 | $26.0M | $108.4M | ||
| Q1 25 | $20.8M | $77.1M | ||
| Q4 24 | $17.8M | $77.3M | ||
| Q3 24 | $42.9M | $61.1M | ||
| Q2 24 | $35.1M | $49.1M | ||
| Q1 24 | $37.7M | $49.5M |
总债务NPKIRIGL
| Q4 25 | $16.9M | $52.5M | ||
| Q3 25 | $9.5M | $60.0M | ||
| Q2 25 | $9.3M | $60.0M | ||
| Q1 25 | $8.1M | $60.0M | ||
| Q4 24 | $7.7M | $60.0M | ||
| Q3 24 | $14.0M | $60.0M | ||
| Q2 24 | $58.0M | $60.0M | ||
| Q1 24 | $77.4M | $60.0M |
股东权益NPKIRIGL
| Q4 25 | $351.2M | $391.5M | ||
| Q3 25 | $333.9M | $117.6M | ||
| Q2 25 | $328.8M | $81.9M | ||
| Q1 25 | $326.9M | $18.6M | ||
| Q4 24 | $326.5M | $3.3M | ||
| Q3 24 | $316.5M | $-14.6M | ||
| Q2 24 | $426.6M | $-29.9M | ||
| Q1 24 | $421.6M | $-31.7M |
总资产NPKIRIGL
| Q4 25 | $441.8M | $513.6M | ||
| Q3 25 | $404.5M | $242.5M | ||
| Q2 25 | $393.7M | $206.7M | ||
| Q1 25 | $390.0M | $176.0M | ||
| Q4 24 | $393.7M | $164.0M | ||
| Q3 24 | $389.6M | $139.4M | ||
| Q2 24 | $624.8M | $128.4M | ||
| Q1 24 | $640.8M | $126.5M |
负债/权益比NPKIRIGL
| Q4 25 | 0.05× | 0.13× | ||
| Q3 25 | 0.03× | 0.51× | ||
| Q2 25 | 0.03× | 0.73× | ||
| Q1 25 | 0.02× | 3.23× | ||
| Q4 24 | 0.02× | 18.25× | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.18× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $5.8M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 16.3% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $26.3M | — |
8季度趋势，按日历期对齐
经营现金流NPKIRIGL
| Q4 25 | $18.0M | $22.0M | ||
| Q3 25 | $24.7M | $24.0M | ||
| Q2 25 | $21.4M | $30.5M | ||
| Q1 25 | $8.8M | $-893.0K | ||
| Q4 24 | $-4.1M | $14.5M | ||
| Q3 24 | $2.8M | $21.7M | ||
| Q2 24 | $27.6M | $302.0K | ||
| Q1 24 | $11.9M | $-5.0M |
自由现金流NPKIRIGL
| Q4 25 | $5.8M | — | ||
| Q3 25 | $12.0M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-17.7M | — | ||
| Q3 24 | $-6.7M | — | ||
| Q2 24 | $21.0M | — | ||
| Q1 24 | $-1.9M | — |
自由现金流率NPKIRIGL
| Q4 25 | 7.6% | — | ||
| Q3 25 | 17.4% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | -1.8% | — | ||
| Q4 24 | -30.8% | — | ||
| Q3 24 | -15.2% | — | ||
| Q2 24 | 31.4% | — | ||
| Q1 24 | -3.9% | — |
资本支出强度NPKIRIGL
| Q4 25 | 16.3% | — | ||
| Q3 25 | 18.5% | — | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 23.6% | — | ||
| Q3 24 | 21.4% | — | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 28.3% | — |
现金转化率NPKIRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 4.37× | 0.86× | ||
| Q2 25 | 2.47× | 0.51× | ||
| Q1 25 | 0.88× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 3.43× | — | ||
| Q1 24 | 1.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NPKI
| Rental Revenue | $34.8M | 46% |
| Products | $25.5M | 34% |
| Services | $14.9M | 20% |
RIGL
暂无分部数据
